Cognito Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Cognito Therapeutics's estimated annual revenue is currently $7.5M per year.
- Cognito Therapeutics's estimated revenue per employee is $104,167
Employee Data
- Cognito Therapeutics has 72 Employees.
- Cognito Therapeutics grew their employee count by 33% last year.
Cognito Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | SVP, Regulatory and Compliance | Reveal Email/Phone |
3 | VP, Clinical Operations | Reveal Email/Phone |
4 | VP, Business Development and Strategic Partnerships | Reveal Email/Phone |
5 | VP Products | Reveal Email/Phone |
6 | Associate Director, Product Management | Reveal Email/Phone |
7 | Director Clinical Affairs | Reveal Email/Phone |
8 | Director Manufacturing | Reveal Email/Phone |
9 | Chief Technology Officer | Reveal Email/Phone |
10 | Director, Hardware Engineering | Reveal Email/Phone |
Cognito Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.5M | 17 | 0% | N/A | N/A |
#2 | N/A | 4 | 0% | N/A | N/A |
#3 | $7.5M | 114 | 7% | N/A | N/A |
#4 | $7.5M | 72 | 33% | N/A | N/A |
#5 | N/A | 17 | 55% | N/A | N/A |
#6 | $7.5M | 48 | -2% | N/A | N/A |
#7 | N/A | 32 | 33% | N/A | N/A |
#8 | N/A | 115 | 37% | N/A | N/A |
#9 | $1.7M | 9 | -18% | N/A | N/A |
#10 | N/A | 70 | -17% | N/A | N/A |
What Is Cognito Therapeutics?
Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical studies demonstrating its investigational therapeutic has the potential to safely slow or stop cognitive decline and loss of brain volume in Alzheimer’s disease. Cognito has received FDA Breakthrough Device Designation for the treatment of Alzheimer’s disease and expects to start pivotal studies in 2022. The company’s technology was based on pioneering optogenetics research by scientific co-founders Professors Li-Huei Tsai and Ed Boyden at MIT.
keywords:N/AN/A
Total Funding
72
Number of Employees
$7.5M
Revenue (est)
33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $11.2M | 72 | -43% | N/A |
#2 | $9.1M | 72 | -21% | N/A |
#3 | $11.2M | 72 | 3% | N/A |
#4 | $11.2M | 72 | 6% | N/A |
#5 | $9.4M | 72 | 13% | N/A |